Vericel Soars 50% On Awaited FDA Approval
December 14, 2016 at 09:25 AM EST
Vericel Corp (NASDAQ: VCEL), a nano-cap commercial-stage biopharmaceutical company that focuses on therapies which enable the body to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.